Titre : Prise de risque

Prise de risque : Questions médicales fréquentes

Termes MeSH sélectionnés :

Economic Development
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Prise de risque : Questions médicales les plus fréquentes", "headline": "Prise de risque : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Prise de risque : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-23", "dateModified": "2025-03-20", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Prise de risque" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Comportement", "url": "https://questionsmedicales.fr/mesh/D001519", "about": { "@type": "MedicalCondition", "name": "Comportement", "code": { "@type": "MedicalCode", "code": "D001519", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F01.145" } } }, "about": { "@type": "MedicalCondition", "name": "Prise de risque", "alternateName": "Risk-Taking", "code": { "@type": "MedicalCode", "code": "D012309", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Natasha Duell", "url": "https://questionsmedicales.fr/author/Natasha%20Duell", "affiliation": { "@type": "Organization", "name": "Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill, 235 E. Cameron Avenue, Chapel Hill, NC 27599-3270, the United States of America." } }, { "@type": "Person", "name": "Laurence Steinberg", "url": "https://questionsmedicales.fr/author/Laurence%20Steinberg", "affiliation": { "@type": "Organization", "name": "Temple University." } }, { "@type": "Person", "name": "Josh Leota", "url": "https://questionsmedicales.fr/author/Josh%20Leota", "affiliation": { "@type": "Organization", "name": "Monash University, Victoria, Australia." } }, { "@type": "Person", "name": "Kyle Nash", "url": "https://questionsmedicales.fr/author/Kyle%20Nash", "affiliation": { "@type": "Organization", "name": "University of Alberta, Edmonton, Canada." } }, { "@type": "Person", "name": "Tsutomu Harada", "url": "https://questionsmedicales.fr/author/Tsutomu%20Harada", "affiliation": { "@type": "Organization", "name": "Graduate School of Business Administration, Kobe University, Kobe, Japan." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "The Potential of Fish Protein Hydrolysate Supplementation in Nile Tilapia Diets: Effects on Growth and Health Performance, Disease Resistance, and Farm Economic Analysis.", "datePublished": "2024-03-15", "url": "https://questionsmedicales.fr/article/38489116", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s12010-024-04913-7" } }, { "@type": "ScholarlyArticle", "name": "Energy and economic analysis of alternatives for the valorization of hydrogen rich stream produced in the aqueous phase reforming of pyrolysis bio-oil aqueous fraction.", "datePublished": "2024-03-14", "url": "https://questionsmedicales.fr/article/38492651", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.biortech.2024.130572" } }, { "@type": "ScholarlyArticle", "name": "Advancing sustainable water treatment strategies: harnessing magnetite-based photocatalysts and techno-economic analysis for enhanced wastewater management in the context of SDGs.", "datePublished": "2024-03-12", "url": "https://questionsmedicales.fr/article/38472580", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11356-024-32680-9" } }, { "@type": "ScholarlyArticle", "name": "The relationship between toxic air pollution, health expenditure, and economic growth in the European Union: fresh evidence from the PMG-ARDL model.", "datePublished": "2024-02-22", "url": "https://questionsmedicales.fr/article/38386160", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11356-024-32342-w" } }, { "@type": "ScholarlyArticle", "name": "Epidemiology and economic burden of Von Hippel-Lindau Disease-associated central nervous system hemangioblastomas and pancreatic neuroendocrine tumors in the United States.", "datePublished": "2024-02-16", "url": "https://questionsmedicales.fr/article/38365728", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13023-024-03060-w" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Comportement et mécanismes comportementaux", "item": "https://questionsmedicales.fr/mesh/D001520" }, { "@type": "ListItem", "position": 3, "name": "Comportement", "item": "https://questionsmedicales.fr/mesh/D001519" }, { "@type": "ListItem", "position": 4, "name": "Prise de risque", "item": "https://questionsmedicales.fr/mesh/D012309" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Prise de risque - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Prise de risque", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-06", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Prise de risque", "description": "Comment évaluer la prise de risque chez un patient ?\nQuels outils diagnostiques sont utilisés ?\nQuels signes cliniques indiquent une prise de risque ?\nLa prise de risque est-elle un trouble ?\nComment la prise de risque est-elle mesurée ?", "url": "https://questionsmedicales.fr/mesh/D012309?mesh_terms=Economic+Development&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Prise de risque", "description": "Quels symptômes sont associés à la prise de risque ?\nLa prise de risque peut-elle causer des symptômes physiques ?\nComment la prise de risque affecte-t-elle la santé mentale ?\nY a-t-il des signes de prise de risque chez les adolescents ?\nQuels comportements sont considérés comme des symptômes de prise de risque ?", "url": "https://questionsmedicales.fr/mesh/D012309?mesh_terms=Economic+Development&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Prise de risque", "description": "Comment prévenir la prise de risque chez les jeunes ?\nQuels rôles jouent les parents dans la prévention ?\nLes programmes scolaires peuvent-ils aider ?\nQuelles activités peuvent réduire la prise de risque ?\nComment les pairs influencent-ils la prise de risque ?", "url": "https://questionsmedicales.fr/mesh/D012309?mesh_terms=Economic+Development&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Prise de risque", "description": "Quels traitements sont disponibles pour la prise de risque ?\nLes médicaments peuvent-ils aider à réduire la prise de risque ?\nComment la thérapie peut-elle aider ?\nY a-t-il des programmes de prévention ?\nLa thérapie familiale est-elle utile ?", "url": "https://questionsmedicales.fr/mesh/D012309?mesh_terms=Economic+Development&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Prise de risque", "description": "Quelles complications peuvent résulter de la prise de risque ?\nLa prise de risque peut-elle entraîner des problèmes de santé ?\nQuels sont les impacts sociaux de la prise de risque ?\nComment la prise de risque affecte-t-elle la vie professionnelle ?\nY a-t-il des conséquences financières liées à la prise de risque ?", "url": "https://questionsmedicales.fr/mesh/D012309?mesh_terms=Economic+Development&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Prise de risque", "description": "Quels facteurs augmentent la prise de risque ?\nLe stress est-il un facteur de risque ?\nLes troubles mentaux influencent-ils la prise de risque ?\nL'alcool joue-t-il un rôle dans la prise de risque ?\nLes influences culturelles affectent-elles la prise de risque ?", "url": "https://questionsmedicales.fr/mesh/D012309?mesh_terms=Economic+Development&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer la prise de risque chez un patient ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'évaluation se fait par des questionnaires et des entretiens cliniques pour comprendre les comportements." } }, { "@type": "Question", "name": "Quels outils diagnostiques sont utilisés ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des échelles de mesure comme le Risk-Taking Questionnaire (RTQ) sont souvent utilisés." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent une prise de risque ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des comportements impulsifs, des décisions hâtives et une minimisation des dangers sont des signes." } }, { "@type": "Question", "name": "La prise de risque est-elle un trouble ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Non, c'est un comportement, mais elle peut être associée à des troubles comme le TDAH." } }, { "@type": "Question", "name": "Comment la prise de risque est-elle mesurée ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Elle est mesurée par des échelles standardisées et des auto-évaluations des comportements." } }, { "@type": "Question", "name": "Quels symptômes sont associés à la prise de risque ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent l'impulsivité, l'irritabilité et des comportements autodestructeurs." } }, { "@type": "Question", "name": "La prise de risque peut-elle causer des symptômes physiques ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress lié à des comportements risqués peut entraîner des symptômes physiques comme des maux de tête." } }, { "@type": "Question", "name": "Comment la prise de risque affecte-t-elle la santé mentale ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut exacerber des troubles comme l'anxiété et la dépression en raison des conséquences." } }, { "@type": "Question", "name": "Y a-t-il des signes de prise de risque chez les adolescents ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des comportements comme la consommation de drogues ou la conduite imprudente sont fréquents." } }, { "@type": "Question", "name": "Quels comportements sont considérés comme des symptômes de prise de risque ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des comportements comme la consommation excessive d'alcool ou la conduite dangereuse sont des symptômes." } }, { "@type": "Question", "name": "Comment prévenir la prise de risque chez les jeunes ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "L'éducation sur les conséquences et le développement de compétences sociales sont essentiels." } }, { "@type": "Question", "name": "Quels rôles jouent les parents dans la prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Les parents doivent communiquer ouvertement et établir des règles claires pour guider leurs enfants." } }, { "@type": "Question", "name": "Les programmes scolaires peuvent-ils aider ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des programmes de sensibilisation et de formation sur la prise de risque sont bénéfiques." } }, { "@type": "Question", "name": "Quelles activités peuvent réduire la prise de risque ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Des activités sportives et artistiques peuvent offrir des alternatives positives aux jeunes." } }, { "@type": "Question", "name": "Comment les pairs influencent-ils la prise de risque ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Les pairs peuvent encourager ou dissuader des comportements à risque, selon le groupe." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour la prise de risque ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les thérapies cognitivo-comportementales et la thérapie de groupe sont efficaces." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils aider à réduire la prise de risque ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments comme les stabilisateurs de l'humeur peuvent être prescrits." } }, { "@type": "Question", "name": "Comment la thérapie peut-elle aider ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie aide à identifier les déclencheurs et à développer des stratégies d'adaptation." } }, { "@type": "Question", "name": "Y a-t-il des programmes de prévention ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des programmes éducatifs ciblent les jeunes pour réduire les comportements à risque." } }, { "@type": "Question", "name": "La thérapie familiale est-elle utile ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut améliorer la communication et réduire les comportements à risque chez les adolescents." } }, { "@type": "Question", "name": "Quelles complications peuvent résulter de la prise de risque ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des blessures physiques, des problèmes juridiques et des troubles mentaux." } }, { "@type": "Question", "name": "La prise de risque peut-elle entraîner des problèmes de santé ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut causer des maladies chroniques, des addictions et des troubles de santé mentale." } }, { "@type": "Question", "name": "Quels sont les impacts sociaux de la prise de risque ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut entraîner l'isolement social, des conflits familiaux et des problèmes relationnels." } }, { "@type": "Question", "name": "Comment la prise de risque affecte-t-elle la vie professionnelle ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut entraîner des absences, des conflits au travail et une baisse de productivité." } }, { "@type": "Question", "name": "Y a-t-il des conséquences financières liées à la prise de risque ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des dépenses médicales et des pertes de revenus peuvent survenir à cause de comportements risqués." } }, { "@type": "Question", "name": "Quels facteurs augmentent la prise de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des facteurs comme l'âge, le sexe, l'environnement social et des antécédents familiaux influencent la prise de risque." } }, { "@type": "Question", "name": "Le stress est-il un facteur de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut augmenter la propension à prendre des risques en raison de l'impulsivité." } }, { "@type": "Question", "name": "Les troubles mentaux influencent-ils la prise de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles comme le TDAH et la dépression sont souvent associés à des comportements à risque." } }, { "@type": "Question", "name": "L'alcool joue-t-il un rôle dans la prise de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la consommation d'alcool peut diminuer les inhibitions et augmenter les comportements risqués." } }, { "@type": "Question", "name": "Les influences culturelles affectent-elles la prise de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines cultures valorisent des comportements à risque, influençant les décisions individuelles." } } ] } ] }

Sources (10000 au total)

Epidemiology and economic burden of Von Hippel-Lindau Disease-associated central nervous system hemangioblastomas and pancreatic neuroendocrine tumors in the United States.

To date, real-world evidence around the clinical and economic burden related to von Hippel-Lindau (VHL) disease is limited. Therefore, this study characterized the prevalence, healthcare resource util... Patients with VHL-CNS-Hb or VHL-pNET were identified from Optum's de-identified Clinformatics® Data Mart Database (2007-2020) and matched 1:5 to control patients without VHL disease or CNS-Hb/pNET. Pr... In 2019, US prevalence rates of VHL-CNS-Hb and VHL-pNET were estimated to be 1.12 cases per 100,000 (3,678 patients) and 0.12 cases per 100,000 (389 patients), respectively. Patients with VHL-CNS-Hb (... In this retrospective, claims-based study, both VHL-CNS-Hb and VHL-pNET were associated with substantial HRU and healthcare costs, particularly tumor reduction surgery-related costs. These findings pr...

Bathing Adaptations in the Homes of Older Adults (BATH-OUT-2): study protocol for a randomised controlled trial, economic evaluation and process evaluation.

The onset of disability in bathing is particularly important for older adults as it can be rapidly followed by disability in other daily activities; this may represent a judicious time point for inter... BATH-OUT-2 is a multicentre, two-arm, parallel-group RCT. Adults aged 60 and over who are referred to their local authority for an accessible level access shower will be randomised, using pairwise ran... The BATH-OUT-2 trial is designed so that the findings will inform future decisions regarding the provision of bathing adaptations for older adults. This trial has the potential to highlight, and then ... ISRCTN Registry ISRCTN48563324. Prospectively registered on 09/04/2021....

The effects of cool roofs on health, environmental, and economic outcomes in rural Africa: study protocol for a community-based cluster randomized controlled trial.

High ambient air temperatures in Africa pose significant health and behavioral challenges in populations with limited access to cooling adaptations. The built environment can exacerbate heat exposure,... We are conducting a 2-year community-based stratified cluster randomized controlled trial (cRCT) implementing sunlight-reflecting roof coatings, known as "cool roofs," as a climate change adaptation i... Our study demonstrates the potential of large-scale cRCTs to evaluate novel climate change adaptation interventions and provide evidence supporting investments in heat resilience in sub-Saharan Africa... German Clinical Trials Register (DRKS) DRKS00023207. Registered on April 19, 2021....

Cost-effectiveness of providing university students with a mindfulness-based intervention to reduce psychological distress: economic evaluation of a pragmatic randomised controlled trial.

Increasing numbers of young people attending university has raised concerns about the capacity of student mental health services to support them. We conducted a randomised controlled trial (RCT) to ex... Economic evaluation conducted alongside a pragmatic, parallel, single-blinded RCT comparing provision of MSS+SAU to SAU.... 616 university students randomised.... The primary economic evaluation assessed the cost per quality-adjusted life year (QALY) gained from the perspective of the university counselling service. Costs relate to staff time required to delive... It was estimated to cost £1584 (2022 prices) to deliver an MSS course to 30 students, £52.82 per student. Both costs (adjusted mean difference: £48, 95% CI £40-£56) and QALYs (adjusted mean difference... MSS leads to significantly improved outcomes at a moderate additional cost. The ICER of £3355 per QALY suggests that MSS is cost-effective when compared with the UK's National Institute for Health and... Australian and New Zealand Clinical Trials Registry, ACTRN12615001160527....

Home-based versus supervised group exercise in men with prostate cancer on androgen deprivation therapy: A randomized controlled trial and economic analysis.

Differences between health outcomes, participation/adoption, and cost-effectiveness of home-based (HOME) interventions and supervised group-based training (GROUP) in men with prostate cancer (PC) on a... This was a multicentre, 2-arm non-inferiority randomized controlled trial and companion cost-effectiveness analysis. Men with PC on ADT were recruited from August 2016 to March 2020 from four Canadian... #NCT02834416.... Thirty-eight participants (mean [standard deviation (SD)] age, 70 [9.0] years) were enrolled (GROUP n = 20; HOME n = 18). There was an 89.8% probability that HOME was non-inferior to GROUP for both fa... A HOME exercise intervention appears non-inferior to GROUP for fatigue and functional endurance and requires fewer resources to implement. HOME appears to ameliorate fatigue more than GROUP, but has c...